Medrogestone produced in accordance with the process of this invention exhibits an HPLC strength in the order of {HEAD ~ 99.2%} with {TAIL ~ total impurities} at about 0.08% , thereby providing a very pure therapeutic agent 
with
Medrogestone produced in accordance with the process of this invention exhibits an HPLC strength in the order of { HEAD ~ 99.2 % } with { TAIL ~ total impurities } at about 0.08 % , thereby providing a very pure therapeutic agent
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH